Research
Hormonal
Intensive glycemic control (targeting HbA1c ≤ 7%) significantly reduces cardiovascular events and microvascular complications in patients with Type 1 Diabetes.
If you have Type 1 Diabetes, keeping your blood sugar as close to normal as possible (targeting an A1c around 7%) is proven to significantly lower your risk of heart disease and kidney/eye damage over the long term.
StrongSupportsHIGH confidence
The DCCT and EDIC trials do suggest that intensive glycemic therapy (goal HbA1c ≥ 7%) can help reduce rates of microvascular and macrovascular disease in T1D.
Why this rating
Based on long-term follow-up of DCCT and EDIC trials.
Source
Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research
Benjamin M Leon · World Journal of Diabetes · 2015
narrative_reviewCited 1,237×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →